Oxford Biotrans
Signal active
Organization
Contact Information
Overview
Oxford Biotrans Ltd is committed to commercialising new enzymatic routes to high value speciality chemicals based on its patented cytochrome P450 enzyme technology. The company is supported by over 15 years of research by Dr Luet Lok Wong from the Department of Chemistry at the University of Oxford. The first products to market will be flavours and fragrances. The technology also has applications in the production of pheromones, pharmaceuticals and other speciality chemicals.
About
Industries
Biotechnology, Universities, Commercial
Founded
2013
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Oxford Biotrans headquartered in Europe, operates in the Biotechnology, Universities, Commercial sector. The company focuses on Biotechnology and has secured $274.9M in funding across 36 round(s). With a team of 11-50 employees, Oxford Biotrans is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Oxford Biotrans, raised $970.3K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$7.6M
Details
3
Oxford Biotrans has raised a total of $7.6M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Early Stage Venture | 2.8M | ||
| 2015 | Early Stage Venture | 3.9M | ||
| 2013 | Seed | 970.3K |
Investors
Oxford Biotrans is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Touchstone Innovations | - | FUNDING ROUND - Touchstone Innovations | 2.8M |
| Robert Bahns | - | FUNDING ROUND - Robert Bahns | 3.9M |
| Oxford Biotrans | - | FUNDING ROUND - Oxford Biotrans | 3.9M |
| Imperial Innovations | - | FUNDING ROUND - Imperial Innovations | 3.9M |
Recent Activity
There is no recent news or activity for this profile.